Ropes & Gray represented Bain Capital in the transaction. Bain Capital completed the sale of its controlling stake in Hugel Inc., a leading biopharmaceutical company based in...
CBC-led Consortium’s Acquisition of Controlling Stake in Hugel
Genesis Research’s Acquisition of Market Access Transformation
Ropes & Gray advised GHO Capital Partners and Genesis Research in the transaction. Macfarlanes advised Market Access Transformation. Genesis Research announced the acquisition of Market Access...
Bain Capital’s Acquisition of a Majority Stake in Classys
Ropes & Gray represented Bain Capital Private Equity in the transaction. Bain Capital Private Equity executed its acquisition, and related financing, of a majority stake in...
Taro Pharmaceutical Industries’ Acquisition of Alchemee
Cravath and Lenz & Staehelin represented Taro in connection with the transaction. Ropes & Gray advised Galderma. Taro Pharmaceutical Industries Ltd. (“Taro”), a multinational, science-based pharmaceutical...
Altus Power’s Business Combination with CBRE Acquisition Holdings
Ropes & Gray advised Altus Power, Simpson Thacher & Bartlett advised CBAH, Skadden, Arps, Slate, Meagher & Flom served as legal counsel to the placement agents....
GHO Capital Partners’ Investment in Biocare Medical
Ropes & Gray represented Global Healthcare Opportunities in the transaction. Global Healthcare Opportunities, or GHO Capital Partners LLP, executed its investment in Biocare Medical. Existing investor...
Galderma’s Acquisition of Alastin Skincare
Ropes & Gray advised Galderma on the deal, while Latham & Watkins advised ALASTIN. Galderma, one of the world’s largest independent dermatology companies, executed its acquisition...
Cinven’s Acquisition of a Stake in BioAgilytix
Ropes & Gray represented GHO Capital in the deal, while White & Case advised BioAgilytix. Kirkland & Ellis advised Cinven. Shearman & Sterling advised the lenders...
GHO Capital’s Acquisition of Genesis Research
Ropes & Gray represented GHO Capital Partners in the transaction. GHO Capital Partners announced its acquisition of Genesis Research. Terms of the transaction were not disclosed....
Accelus’s $482 Million Combination with CHP Merger Corporation
Cadwalader advised Integrity Implants on the deal, while Ropes & Gray advised CHP Merger Corp. Integrity Implants Inc. (d/b/a Accelus) entered into its definitive business combination...
LianBio’s $325 Million Initial Public Offering
Zhong Lun and Ropes & Gray advised LianBio on the deal. LianBio executed an initial public offering and listing of American depositary shares on the Nasdaq...
Thomas H. Lee Equity Fund IX’s $5.6 Billion Fundraising
Ropes & Gray advised Thomas H. Lee Partners on the transaction. Thomas H. Lee Partners, L.P., a premier private equity firm investing in middle-market growth companies,...